Phase II Study of Pallidotomy for Parkinson Disease
I. Evaluate the safety and efficacy of pallidotomy immediately following 3 preoperative assessments vs. delayed pallidotomy following 6 months of standard medical therapy in patients with Parkinson disease.
|Study Design:||Allocation: Randomized
Primary Purpose: Treatment
|Study Start Date:||October 1994|
PROTOCOL OUTLINE: This is a randomized study. One group of patients undergoes the surgical procedure pallidotomy, a precise lesioning of brain cells in the globus pallidus.
The other group receives standard medical care for 6 months followed by a pallidotomy.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004670
|Study Chair:||Mahlon R. DeLong||Emory University|